Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

1 Feb 2019 16:35

RNS Number : 8968O
Silence Therapeutics PLC
01 February 2019
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PMEBLGDDUXGBGCB
Date   Source Headline
17th Feb 20217:00 amRNSFirst dosing for SLN360
15th Feb 20213:55 pmRNSHolding(s) in Company
15th Feb 20211:14 pmRNSHolding(s) in Company
12th Feb 20214:57 pmRNSHolding(s) in Company
12th Feb 20214:53 pmRNSHolding(s) in Company
12th Feb 202112:10 pmRNSAdditional Listing and Total Voting Rights
11th Feb 20215:29 pmRNSHolding(s) in Company
11th Feb 202111:06 amRNSHolding(s) in Company
8th Feb 20214:28 pmRNSAdditional listing and Total Voting Rights
5th Feb 20217:00 amRNSSilence Announces $45m Private Placement
29th Jan 20212:35 pmRNSAdditional listing and Total Voting Rights
25th Jan 202112:41 pmRNSAdditional listing and Total Voting Rights
7th Jan 20217:00 amRNSHoldings in Company
6th Jan 202111:08 amRNSGrant of Options
6th Jan 202110:08 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSBoard of Directors Appointment
6th Jan 20217:00 amRNSSilence Therapeutics Appoints Craig Tooman as CFO
5th Jan 20217:00 amRNSJanuary Conference Schedule
4th Jan 202111:45 amRNSHoldings in Company
15th Dec 202012:28 pmRNSHolding(s) in Company
4th Dec 20205:08 pmRNSAdditional listing and Total Voting Rights
3rd Dec 20209:45 amRNSDirector/PDMR Shareholding
3rd Dec 20209:44 amRNSDirector/PDMR Shareholding
17th Nov 20203:44 pmRNSAdditional listing and Total Voting Rights
16th Nov 20207:00 amRNSPositive pre-clinical data presented
2nd Nov 20207:00 amRNSSilence Therapeutics Appoints Dr. Marie Wikström
29th Oct 20204:41 pmRNSSecond Price Monitoring Extn
29th Oct 20204:36 pmRNSPrice Monitoring Extension
16th Oct 20202:05 pmRNSDirector/PDMR Shareholding
14th Oct 20201:15 pmRNSAdditional listing and Total Voting Rights
12th Oct 20203:49 pmRNSDirector/PDMR Shareholding
8th Oct 20207:00 amRNSChange to Executive Leadership Team
6th Oct 20204:25 pmRNSAdditional Listing and Total Voting Rights
1st Oct 20207:00 amRNSConference Participation
23rd Sep 20208:59 amRNSHolding(s) in Company
23rd Sep 20207:06 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
22nd Sep 20204:40 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:05 amRNSGrant of options
14th Sep 20207:00 amRNSSilence Therapeutics announces new CEO
14th Sep 20207:00 amRNS2020 interim results
8th Sep 20207:01 amRNSR&D update
8th Sep 20207:00 amRNSInstructions exchanging ordinary shares for ADSs
8th Sep 20207:00 amRNSCompletion of Nasdaq listing
7th Sep 20205:47 pmRNSHolding(s) in Company
4th Sep 20202:18 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSSilence to Participate in US Investor Conferences
1st Sep 20207:00 amRNSSilence Therapeutics Notice of Results
21st Aug 20207:00 amRNSSilence Therapeutics Files Registration with SEC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.